| Dr Thomas B Anderson, MD,PHD | |
|
1500 Sw 10th Ave, Topeka, KS 66604-1301 | |
| (785) 354-5242 | |
| Not Available |
| Full Name | Dr Thomas B Anderson |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 33 Years |
| Location | 1500 Sw 10th Ave, Topeka, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396794772 | NPI | - | NPPES |
| 200408560C | Medicaid | KS | |
| 068002080 | Other | KS | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 04-32232 (Kansas) | Primary |
| 207R00000X | Internal Medicine | 04-32232 (Kansas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stormont Vail Hospital | Topeka, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
The National Association For Continence (NAFC) has updated the Male Stress Urinary Incontinence content at www.nafc.org. The new content is designed to be more patient friendly and includes an educational video, as well as additional resources about the diagnosis, treatment, and management of Male Stress Urinary Incontinence.
Current techniques used to clean endoscopes for reuse are not consistently effective, according to a study published in the February issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology.
Three international teams of scientists, led by researchers at the University of California San Diego, University of Michigan and Stanford University, have published a trio of papers describing in unprecedented detail the structure and workings of G protein-coupled receptors (GPCRs), a large family of human proteins that are the target of one-third to one-half of modern drugs.
President Obama and Mitt Romney faced off Tuesday night in a scrappy, at times downright nasty town-hall debate that featured a feistier, more focused Obama than was seen in their first encounter and that broadened the discussion to social issues such as immigration, contraceptive coverage and gun control. ... In the end, on the domestic front, the debate performance of both has been about as disappointing as their dodging on the campaign trail.
› Verified 5 days ago
| Entity Name | Cotton O'neil Clinic Revocable Trust |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
The National Association For Continence (NAFC) has updated the Male Stress Urinary Incontinence content at www.nafc.org. The new content is designed to be more patient friendly and includes an educational video, as well as additional resources about the diagnosis, treatment, and management of Male Stress Urinary Incontinence.
Current techniques used to clean endoscopes for reuse are not consistently effective, according to a study published in the February issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology.
Three international teams of scientists, led by researchers at the University of California San Diego, University of Michigan and Stanford University, have published a trio of papers describing in unprecedented detail the structure and workings of G protein-coupled receptors (GPCRs), a large family of human proteins that are the target of one-third to one-half of modern drugs.
President Obama and Mitt Romney faced off Tuesday night in a scrappy, at times downright nasty town-hall debate that featured a feistier, more focused Obama than was seen in their first encounter and that broadened the discussion to social issues such as immigration, contraceptive coverage and gun control. ... In the end, on the domestic front, the debate performance of both has been about as disappointing as their dodging on the campaign trail.
› Verified 5 days ago
| Entity Name | Stormont Vail Health Flint Hills Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952018608 PECOS PAC ID: 9032587472 Enrollment ID: O20230429000051 |
News Archive
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
The National Association For Continence (NAFC) has updated the Male Stress Urinary Incontinence content at www.nafc.org. The new content is designed to be more patient friendly and includes an educational video, as well as additional resources about the diagnosis, treatment, and management of Male Stress Urinary Incontinence.
Current techniques used to clean endoscopes for reuse are not consistently effective, according to a study published in the February issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology.
Three international teams of scientists, led by researchers at the University of California San Diego, University of Michigan and Stanford University, have published a trio of papers describing in unprecedented detail the structure and workings of G protein-coupled receptors (GPCRs), a large family of human proteins that are the target of one-third to one-half of modern drugs.
President Obama and Mitt Romney faced off Tuesday night in a scrappy, at times downright nasty town-hall debate that featured a feistier, more focused Obama than was seen in their first encounter and that broadened the discussion to social issues such as immigration, contraceptive coverage and gun control. ... In the end, on the domestic front, the debate performance of both has been about as disappointing as their dodging on the campaign trail.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas B Anderson, MD,PHD 1500 Sw 10th Ave, Topeka, KS 66604-1301 Ph: (785) 354-5242 | Dr Thomas B Anderson, MD,PHD 1500 Sw 10th Ave, Topeka, KS 66604-1301 Ph: (785) 354-5242 |
News Archive
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
The National Association For Continence (NAFC) has updated the Male Stress Urinary Incontinence content at www.nafc.org. The new content is designed to be more patient friendly and includes an educational video, as well as additional resources about the diagnosis, treatment, and management of Male Stress Urinary Incontinence.
Current techniques used to clean endoscopes for reuse are not consistently effective, according to a study published in the February issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology.
Three international teams of scientists, led by researchers at the University of California San Diego, University of Michigan and Stanford University, have published a trio of papers describing in unprecedented detail the structure and workings of G protein-coupled receptors (GPCRs), a large family of human proteins that are the target of one-third to one-half of modern drugs.
President Obama and Mitt Romney faced off Tuesday night in a scrappy, at times downright nasty town-hall debate that featured a feistier, more focused Obama than was seen in their first encounter and that broadened the discussion to social issues such as immigration, contraceptive coverage and gun control. ... In the end, on the domestic front, the debate performance of both has been about as disappointing as their dodging on the campaign trail.
› Verified 5 days ago
Dr. Amer Alshekh Mousa, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-5242 | |
Jeffery Parker Rhoads, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 7821 Sw 12th St, Topeka, KS 66615 Phone: 785-408-5824 | |
Achuta Uppu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-6000 | |
Dr. Keith E Kentch, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-5242 | |
Ashraf Alhafez, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 Sw 10th Ave, Stormont-vail Health Care, Topeka, KS 66604 Phone: 785-354-5242 | |
Corbin J Mcilvain, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-5242 | |
Dr. Hossam Saher Ahmad Abed, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-5242 |